Supply of Public Health Products for Automated Kiosk Dispensing City of Atlantic

Summary (Newest Update)

Background The City of Atlantic City is seeking a qualified supplier to provide public health, harm reduction, and sexual health products for use in City-owned automated kiosk dispensing machines located at various designated sites. This procurement focuses solely on the supply of products, with the vendor not responsible for providing, leasing, owning, or maintaining the kiosk equipment. Work Details The selected supplier will furnish, deliver, and replenish approved public health products for automated dispensing in quantities and configurations as prescribed by the City. Products will be stocked and dispensed through three City-owned kiosks, with delivery schedules determined by usage and inventory levels. Eligible products include: - Harm Reduction Supplies: Naloxone (Narcan) kits or FDA-approved equivalents, fentanyl test strips, xylazine test strips, syringes and injection supplies (where permitted), alcohol prep pads, disposal and safety materials. - Sexual Health Products: Condoms (latex and non-latex), lubricants, educational materials, emergency contraception (Plan B One-Step or FDA-approved equivalents), STI/HIV testing kits including HIV self-test kits. - Other Products: Any additional public health items authorized by the City during the contract term. All supplied products must be new, unused, unexpired, meet FDA/CDC/New Jersey Department of Health requirements, and be suitable for automated vending/kiosk dispensing. Period of Performance The initial term of the contract is one year with optional renewal periods at the City's discretion. Place of Performance The contract will be performed in Atlantic City, located in Atlantic County, New Jersey. Bidder Requirements Suppliers must maintain appropriate business licensing and product liability insurance. They must also possess any required pharmaceutical or medical supply distribution licenses. Additionally, suppliers are required to certify that they are not listed on the State Department of Treasury's Chapter 25 list regarding investment activities in Iran.